| |
|
| GENERAL CHAPTERS |
|
726 Electrophoresis |
1196 Pharmacopeial Harmonization |
1081 Gel Strength of Gelatin |
|
| |
|
| USP MONOGRAPHS |
|
| Carbon Monoxide C 11 |
Neomycin Sulfate and Triamcinolone Acetonide Ophthalmic Ointment |
| Flumazenil C 11 Injection |
Water O 15 Injection |
| Mespiperone C 11 Injection |
Oxytocin Nasal Solution |
| Methionine C 11 Injection |
Physostigmine |
| Raclopride C 11 Injection |
Physostigmine Sulfate |
| Sodium Acetate C 11 Injection |
Physostigmine Sulfate Ophthalmic Ointment |
| Chloramphenicol, Polymyxin B Sulfate, and Hydrocortisone Acetate Ophthalmic Ointment |
Plicamycin |
| Chloramphenicol and Prednisolone Ophthalmic Ointment |
Plicamycin for Injection |
| Corticotropin Zinc Hydroxide Injectable Suspension |
Polyoxyl 40 Stearate |
| Fluorodopa F 18 Injection |
Propranolol Hydrochloride and Hydrochlorothiazide Extended-Release Capsules |
| Isoflurophate |
Reserpine, Hydralazine Hydrochloride, and Hydrochlorothiazide Tablets |
| Isoflurophate Ophthalmic Ointment |
Scopolamine Hydrobromide Ophthalmic Ointment |
| Neomycin Sulfate and Hydrocortisone Acetate Ophthalmic Ointment |
Tetracaine Ophthalmic Ointment |
| Neomycin Sulfate and Prednisolone Acetate Ophthalmic Ointment |
Vidarabine |
| Neomycin Sulfate and Prednisolone Sodium Phosphate Ophthalmic Ointment |
Vidarabine Ophthalmic Ointment |
| Neomycin Sulfate, Sulfacetamide Sodium, and Prednisolone Acetate Ophthalmic Ointment |
|
| |